Person

Omar Ishrak

Director, Amgen

Current S&P 500 boards
1
Current roles
1
Open-market buys
$3.5M
Open-market sales
$26.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • INTC
    Intel
    Director
    Mar 2017 – last filing Apr 2025
  • MDT
    Medtronic
    DirectorExecutive Chairman
    2016 or earlier – last filing Dec 2020

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jan 30, 2023INTCBuy86$28.05$2K
Feb 22, 2022INTCBuy11,025$45.11$497K
Oct 28, 2021INTCBuy20,000$48.02$960K
Oct 9, 2020MDTSale763$108.40$83K
Feb 20, 2020MDTBuy8,771$113.68$997K
Jan 9, 2019MDTBuy12,000$84.05$1.0M
Sep 15, 2017MDTSale140,407$81.63$11.5M
Mar 15, 2017MDTSale95,000$82.82$7.9M
Sep 15, 2016MDTSale61,925$84.93$5.3M
Mar 17, 2016MDTSale22,699$76.12$1.7M
Mar 17, 2016MDTSale1,100$76.90$85K

SEC reporting-owner ID (CIK) 1523102 · all filings on EDGAR

Omar Ishrak (AMGN) | USBoard